M&G plc’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.8M Buy
17,469
+2,113
+14% +$189K 0.01% 302
2026
Q1
$1.11M Buy
15,356
+2,782
+22% +$214K 0.01% 328
2025
Q4
$993K Sell
12,574
-5,718
-31% -$451K 0.01% 325
2025
Q3
$1.37M Hold
18,292
0.01% 320
2025
Q2
$1.26M Sell
18,292
-36,779
-67% -$2.41M 0.01% 327
2025
Q1
$3.74M Sell
55,071
-712,488
-93% -$42.6M 0.02% 288
2024
Q4
$34.5M Sell
767,559
-142,116
-16% -$7.97M 0.21% 104
2024
Q3
$57.3M Buy
909,675
+18,955
+2% +$1.11M 0.21% 87
2024
Q2
$52.6M Buy
890,720
+110,050
+14% +$6.88M 0.21% 81
2024
Q1
$62.5M Buy
+780,670
New +$59.6M 0.24% 70

Other funds holding CVS

M&G plc's CVS Position: Q2 2026 in Review

M&G plc increased its CVS Health (CVS) stake by 14% in Q2 2026, buying an estimated $189K and bringing the position to 17,469 shares worth $1.8M. The position accounts for 0.01% of the portfolio, ranked #302.

M&G plc first reported a position in CVS in Q1 2024 and has held it in 10 quarters since. The position peaked at $62.5M in Q1 2024. 2,064 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • M&G plc held 17,469 shares of CVS Health worth $1.8M as of Q2 2026.
  • M&G plc bought 2,113 CVS Health shares in Q2 2026, an estimated $189K.
  • CVS Health made up 0.01% of M&G plc's portfolio in Q2 2026, its #302 holding.
  • M&G plc first reported a position in CVS Health in Q1 2024 and has held it in 10 quarters since.
  • M&G plc's CVS Health position peaked at $62.5M in Q1 2024.
  • 2,064 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on M&G plc's 13F filing for Q2 2026, filed 6 Aug 2026.